Adolescent Polycystic Ovary Syndrome on a Low-carbohydrate Diet
NCT06429618
Adnexal Diseases, Adolescent Behavior
Ankara, Turkey (Türkiye)
View Trial DetailsNCT Number: NCT01859663
The purpose of the study is to identify lifestyle factors associated with PCOS and understand how diet and activity levels impact features of PCOS. The secondary aim is to examine psychosocial factors (e.g., health beliefs) of women with PCOS.
Looking for future studies?
Notify Me18 year–48 year
Female
Observational
Human Metabolic Research Unit, Cornell University, Ithaca, New York, United States
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects 6-12% of reproductive-aged women within the general population. Currently, there is limited knowledge on the current lifestyles of women with PCOS and the psychosocial factors associated with PCOS.
The researchers plan to examine potential lifestyle differences and psychosocial factors between PCOS and healthy women. The Research Team is also interested in the relationships between biological markers and lifestyle endpoints in women with and without PCOS. Previous literature has shown there are biological marker differences between those with and without PCOS. By examining these relationships, researchers may further understand whether PCOS status is associated with lifestyle parameters.
To accomplish these objectives, 360 women (120 women with PCOS, 120 women without PCOS and with normal menstrual cycles, and 120 women without PCOS and with irregular menstrual cycles) will be included in this study. An equal number of lean and overweight/obese women will be recruited within each group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2). Women will be included in the PCOS group if they have a confirmed PCOS diagnosis from their primary care provider. Participants will complete a food frequency questionnaire, a sleep questionnaire, and a physical activity questionnaire. A researcher may also provide participants with a waist-worn accelerometer to monitor physical activity and a wrist-worn accelerometer to monitor sleep for a week. Ultrasound scans of the ovaries will be assessed and the following metabolic parameters will be assessed: (1) 75-gram oral glucose tolerance test; (2) dual X-ray absorptiometry (DXA) scan; (3) vitals and anthropometry assessment to measure waist and hip circumference, height, weight, blood pressure, and heart rate; (4) fasting blood tests to detect androgens (i.e., total testosterone, androstenedione, free androgen index); and (5) an (optional) subcutaneous fat biopsy. Women with and without PCOS will also be asked to complete a questionnaire that will assess the psychosocial factors (e.g., health beliefs). This can be conducted online, in person, or through phone.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 week
A food frequency questionnaire will be administered to assess diet composition for the last three months.
Time frame: 1 week
An accelerometer will be administered to assess physical activity for 1 week.
Time frame: 1-2 weeks
A questionnaire will be administered to assess psychosocial factors of women with PCOS.
Time frame: 6 consecutive nights
A wrist-worn accelerometer will be administered to assess sleep patterns for 6 consecutive nights.
Time frame: 1 day
The ratio of circulating LH to FSH concentrations in the serum will be determined for each participant and compared across groups
Time frame: 1 day
Degree of hirsutism as judged by the Ferriman-Gallwey scale will be determined and compared across groups
Degree of hirsutism as judged by the Ferriman-Gallwey scale will be determined and compared across groups
Time frame: 1 day
Total testosterone, androstenedione and free androgen index concentrations in serum will be determined and compared across groups.
Time frame: 1 day
Average menstrual cycle length as determined by self-reported history will be determined and compared across groups
Time frame: 1 day
The ratio of weight to height will be determined and compared across groups.
Time frame: 1 day
The ratio of waist circumference to hip circumference will be determined and compared across groups
Time frame: 1 day
The size of each ovary will be determined using ultrasonography for each participant during study participation and compared between groups.
Time frame: 1 day
Insulin sensitivity will be determined by administration of an oral glucose tolerance test and compared between groups.
Time frame: 1 day
The serum progesterone concentration will be determined during study participation, assessed in association with luteal dynamics and compared between groups.
Time frame: 1 day
Blood pressure will be determined and compared between groups.
Time frame: 1 day
Lipids, glucose and HbA1C concentrations will be determined and compared between groups.
Time frame: 1 day
Percentage and distribution of fat and lean mass as assessed using DXA technology will be compared between groups.
Time frame: 1 day
Subcutaneous fat cells, which represent important sites of reproductive hormone synthesis, will be assessed and compared across groups
Cornell University
Other
Baseline Assessment of Dietary Intake and Physical Activity in Women With Polycystic Ovary Syndrome (PCOS)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06429618
Adnexal Diseases, Adolescent Behavior
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05394935
Adnexal Diseases, Behavior
Cardiff, United Kingdom
View Trial DetailsNCT06442189
Adnexal Diseases, Behavior
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06426771
AMH, Adnexal Diseases
Ankara, Turkey (Türkiye)
View Trial Details